Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives / Q000145:classification / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology; D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D013329:Structure-Activity Relationship
D000662:Amphetamines; D006213:Hallucinogens; C051570:N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine; D015104:3,4-Methylenedioxyamphetamine; D000661:Amphetamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine